Last checked at 22 Oct 2020 07:00
EKF Diagnostics Holdings plc
("EKF", the "Company" or the "Group")
New supply orders for COVID-19 sample collection kits
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it has received initial orders for PrimeStore MTM COVID-19 sample collection devices from two new customers, the Health Service Executive ("HSE"), Ireland and a national health body in England. These orders will be fulfilled from EKF's production facilities in Penarth, South Wales and Barleben, Germany.
These orders will contribute to the expected strong Q4 performance and the Company intends to provide a further update on trading in early November.
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com | |
Christopher Mills, Non-executive Chairman | Tel: +44 (0) 29 2071 0570 | |
Julian Baines, CEO | ||
Richard Evans, FD & COO | ||
N+1 Singer | Tel: 020 7496 3000 | |
Aubrey Powell / George Tzimas (Corporate Finance)Tom Salvesen (Corporate Broking) | ||
Walbrook PR Limited | Tel: +44 (0) 20 7933 8780 or ekf@walbrookpr.com | |
Paul McManus / Lianne Cawthorne | Mob: +44 (0) 7980 541 893 / +44 (0) 7584 391 303 | |
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.
About PrimeStore MTM
The PrimeStore MTM sample collection device, deactivates viruses, bacteria, fungi and mycobacterium tuberculosis allowing safe sample handling and transport, greatly reducing risk of infection. The device was invented by Longhorn Vaccines and Diagnostics LLC ("Longhorn") in the US, in 2006 in preparation for a worldwide pandemic and is designed to de-activate pathogen rapidly and stabilise the RNA for up to four weeks with no requirement for cold storage. In the case of COVID-19, by deactivating the virus testing can now take place outside of containment facilities opening up capacity in more testing laboratories. With the flu season approaching, the PrimeStore MTM can also safely collect flu and COVID-19 samples in the same collection kit.
PrimeStore MTM was successfully evaluated for effective SARS-CoV-2 inactivation in a study published by PHE. The study showed that of the few transport reagents, from the 23 tested, where no residual virus was detectable, PrimeStore MTM is the only commercially available CE-marked and FDA cleared transport media. EKF is a contract manufacturer for the PrimeStore MTM sample collection device.